ArticleScientific reports2017

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.

Zoltan Lohinai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.